Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.25 +0.00 (+0.40%)
As of: Oct 2, 2026 · 11:29 AM EDT

Sonoma Pharmaceuticals (SNOA) Accumulated Expenses (2011)

Updated

Sonoma Pharmaceuticals' Accumulated Expenses was $736,000 in fiscal Q2 2012 (quarter ended Sep 30, 2011), down 37.1% from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Accumulated Expenses (2011) Analysis & Trends

At the end of FY2011 (ended Mar 31, 2011), Accumulated Expenses at Sonoma Pharmaceuticals came in at $694,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Sonoma Pharmaceuticals 4.92 Mn -8.41 Mn 2.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 736,000.00
Jun 30, 2011 1.17 Mn
Mar 31, 2011 694,000.00
API Access

Sonoma Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SNOA&period=max&api_key=YOUR_API_KEY